NEW YORK, April 29, 2019 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:
To: All Persons or Entities who purchased Aratana Therapeutics, Inc. (“Aratana” or the “Company”) (NASDAQGM: PETX) stock prior to April 26, 2019.
You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Aratana to Elanco Animal Health Incorporated (NYSE: ELAN). Under the terms of the transaction, Aratana shareholders will receive 0.1481 shares of Elanco common stock and a contingent value right representing $0.25 in cash for each Aratana share they own. To learn more about the action and your rights, go to:
https://www.zlk.com/mna/aratana-therapeutics-inc-2
or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972. There is no cost or obligation to you.
The Aratana merger investigation concerns whether the Board of Aratana breached their fiduciary duties to stockholders by failing to adequately shop the Company before agreeing to enter into this transaction, and whether Elanco Animal Health Incorporated is underpaying for Aratana shares, thus unlawfully harming Aratana shareholders.
Levi & Korsinsky is a national firm with offices in New York, Connecticut, California, and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities lawsuits and have recovered hundreds of millions of dollars for aggrieved shareholders. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com